- Home
- SGMT vs FCAP Comparison
SGMT vs FCAP Comparison
Compare SGMT & FCAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | SGMT | FCAP |
|---|---|---|
| Founded | 2006 | 1891 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Savings Institutions |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 169.4M | 176.1M |
| IPO Year | 2021 | 1998 |
Fundamental Metrics
Financial Performance| Metric | SGMT | FCAP |
|---|---|---|
| Price | $6.43 | $54.50 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $26.38 | N/A |
| AVG Volume (30 Days) | ★ 396.0K | 2.2K |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 2.28% |
| EPS Growth | N/A | ★ 36.97 |
| EPS | N/A | ★ 4.89 |
| Revenue | $2,000,000.00 | ★ $7,170,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.15 |
| Revenue Growth | N/A | ★ 1.57 |
| 52 Week Low | $2.36 | $33.88 |
| 52 Week High | $11.41 | $71.00 |
Technical Indicators
Market Signals| Indicator | SGMT | FCAP |
|---|---|---|
| Relative Strength Index (RSI) | 66.99 | 61.76 |
| Support Level | $6.30 | $49.64 |
| Resistance Level | $6.72 | $63.70 |
| Average True Range (ATR) | 0.35 | 1.76 |
| MACD | 0.16 | 0.41 |
| Stochastic Oscillator | 90.69 | 92.72 |
Price Performance
Historical ComparisonAbout SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
About FCAP First Capital Inc.
First Capital Inc is an Indiana chartered commercial bank that provides a variety of banking services to individuals and businesses. It provides retail and business banking, residential mortgage lending, real estate finance, and asset-based lending. The bank's primary source of revenue is real estate mortgage loans.